Release date: 2007-10-30
British scientists found that hydroxychloroquine can improve the survival rate of lupus patients According to the "Rheumatology Annual Report", the use of hydroxychloroquine in the systemic lupus erythematosus (SLE) survivors produced a clear protective effect.
Dr. Graciela S. Alarcn of the University of Alabama in Birmingham and colleagues were enrolled in 608 patients with multi-ethnic SLE for follow-up.
After 39 months, 61 people died, 17 of them took hydroxychloroquine (n = 349, 5% died), 44 were unaccompanied (n = 259, 17% died; p
The researchers point out that hydroxychloroquine has a protective effect, probably because it prevents recurrence and damage, thereby preventing death. Antimalarials such as hydroxychloroquine are anticoagulant, antihyperlipidemic, antihyperglycemic, and thus prevent thrombosis. Patients with lupus should take hydroxychloroquine as much as possible, but should not exceed 6.5mg/kg of ideal body weight, and at the same time strengthen ophthalmology monitoring. ——China Medicine 123 Network
Curing Agent For Epoxy Resin,High Grade Epoxy Resin Curing Agent,Liquid Epoxy Resin Curing Agent,
Ningxia Darong Chemicals & Metallurgy Co., Ltd. , https://www.darong-cyanamide.com